Lifevantage Corp (LFVN) stock
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3043% below fair value
$4.81+0.03 (+0.63%)
Close on Nov 18, 2026Market cap $60.26MP/E 12.0Yield 3.85%
Lifevantage free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Lifevantage's free cash flow for the twelve months ending Jun 30, 2026 was $6.67M, down 36.5% year over year. For fiscal 2026 it was $6.67M, down 36.5% from the year before. Over ten years it grew 2.0% a year on average. The highest annual figure on record is $17.20M in fiscal 2012.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $6.67M | -36.5% |
| FY2025 | Jun 30, 2025 | $10.51M | +5.6% |
| FY2024 | Jun 30, 2024 | $9.95M | +164.6% |
| FY2023 | Jun 30, 2023 | $3.76M | -41.5% |
| FY2022 | Jun 30, 2022 | $6.43M | -48.7% |
| FY2021 | Jun 30, 2021 | $12.53M | -19.9% |
| FY2020 | Jun 30, 2020 | $15.65M | +2.4% |
| FY2019 | Jun 30, 2019 | $15.28M | +77.6% |
| FY2018 | Jun 30, 2018 | $8.61M | +55.3% |
| FY2017 | Jun 30, 2017 | $5.54M | +1.2% |
| FY2016 | Jun 30, 2016 | $5.47M | -54.6% |
| FY2015 | Jun 30, 2015 | $12.06M | +18.2% |
| FY2014 | Jun 30, 2014 | $10.21M | +82.9% |
| FY2013 | Jun 30, 2013 | $5.58M | -67.5% |
| FY2012 | Jun 30, 2012 | $17.20M | +277.2% |
| FY2011 | Jun 30, 2011 | $4.56M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $3.73M | +346.7% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $3.98M | +109.6% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $1.71M | -80.4% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$2.74M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $835.00K | -63.8% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $1.90M | -32.3% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $8.71M | +617.2% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$932.00K | -125.7% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $2.30M | -29.1% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $2.80M | +14.2% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $1.21M | +833.8% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $3.63M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $3.25M | +29.3% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $2.45M | +701.6% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $130.00K | -96.3% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$2.07M | -2481.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $2.51M | -68.2% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $306.00K | -77.0% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $3.52M | -33.8% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $87.00K | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $7.89M | -10.0% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $1.33M | -51.4% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $5.32M | -36.2% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$2.01M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $8.78M | +42.3% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $2.74M | +11.9% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $8.34M | +90.1% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$4.21M | -284.7% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $6.17M | +47.2% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $2.45M | +32.0% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $4.39M | +254.6% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $2.28M | +71.8% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $4.19M | +202.5% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $1.85M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $1.24M | -40.4% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $1.33M | -52.4% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $1.39M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$706.00K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $2.08M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $2.79M | – |
See a number that looks wrong?